FDA NDC Directory · JSON-LD · Markdown

Oxybutynin Chloride

NDC 50111-456 · HUMAN PRESCRIPTION DRUG · TABLET

Labeler / ManufacturerTeva Pharmaceuticals USA, Inc.
Marketing categoryAbbreviated NDA (generic) · App ANDA071655
Dosage form / routeTABLET · ORAL
Active ingredientsOXYBUTYNIN CHLORIDE (5 mg/1)
Marketing started19900930
Package count3

External sources

Source: openFDA. Public-domain (CC0).